Metropolis Healthcare acquires Core Diagnostics in INR 246.8 crore deal
Strategic acquisition to strengthen advanced cancer diagnostics and expand market presence across northern and eastern India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer diagnostics
How liquid biopsies, AI, and multi-cancer screening are transforming early diagnosis and patient…
Dinesh Chauhan, CEO, CORE Diagnostics explains that the rising cancer burden, requires progressions critical for timely and…
Healthcare Global Enterprises partners with Trucan Diagnostics
Collaboration aims to validate next-generation tests for the detection of primary and recurrent/metastatic cancer and personalised…
Rare compound mutation of EGFR L858R and E709A identified in lung adenocarcinoma patient
This discovery demonstrates the clinical utility of liquid biopsy in identifying rare mutations, aiding in more accurate…